Key insights
- Medline launched Mpower, an AI-powered supply chain platform developed with Microsoft, aimed at improving efficiency for healthcare providers. Early data shows significant gains in order substitution workflows. Medline's upcoming earnings report and current overvaluation based on InvestingPro analysis add context. The news signals a potential positive for Medline and a broader trend of AI adoption in healthcare, but its immediate impact on the overall US equity market is limited.
NORTHFIELD, Ill. - Medline (NASDAQ:MDLN) announced today the availability of Mpower, a cloud-based supply chain technology platform developed with Microsoft to help healthcare providers manage supply chain disruptions. The $58.8 billion healthcare equipment company, recognized as a prominent player in the Healthcare Equipment & Supplies industry according to InvestingPro, generated $28.4 billion in revenue over the last twelve months with growth of 11.5%.
The platform functions as a digital control tower that uses predictive analytics and workflow automation to provide real-time visibility into inventory, demand forecasts and supply network vulnerabilities, according to a company press release. Mpower integrates an AI chat agent that allows users to query product alternatives and process clinical approvals within the system.
The technology was developed following an early release program involving 10 U.S. health systems that tested and provided input on the platform. Initial data from these systems showed efficiency gains exceeding 50% in order substitution workflows compared to a baseline period of five to seven days without the platform. Health systems using Mpower alongside Medline’s AutoSub program reported fill-rate increases of 1-2%.The platform launch comes as Medline trades at a P/E ratio of 33.3, with InvestingPro analysis indicating the stock is currently overvalued relative to its Fair Value. The company has been profitable over the last twelve months and is set to report earnings in two days on May 6. Investors seeking deeper insights can access one of over 1,400 comprehensive Pro Research Reports available for US equities, which transform complex financial data into clear, actionable intelligence.
"Mpower reflects how we approach technology at Medline - building practical solutions in close collaboration with partners and customers," said Marshall Lancaster, Medline chief information officer. "Working with Microsoft, we focused on creating a cloud-based platform that can be deployed efficiently, integrates seamlessly into existing environments and delivers meaningful value from day one."
The platform runs on Microsoft Azure and integrates with Microsoft Office 365. It draws on Medline’s supply chain data from its operations as both a manufacturer and distributor to provide insights on inventory positions and potential supply chain risks.
Marc Phillips, Medline senior vice president of supply chain solutions, stated the technology was developed in response to healthcare providers requesting improved visibility and workflow management tools for global supply chain complexity.
Medline plans to roll out Mpower to customers in phases throughout 2026, with additional capabilities planned as the platform develops. The company is headquartered in Northfield, Illinois, and employs more than 45,000 people worldwide.
In other recent news, Medline announced the completion of a secondary offering where 86.25 million shares of Class A common stock were sold by stockholders at $41 each. The offering included an additional 11.25 million shares purchased by underwriters. Meanwhile, Tigress Financial Partners raised its price target for Medline to $60, maintaining a Buy rating, citing durable growth levers and AI-driven operating efficiencies. BTIG also reaffirmed a Buy rating with a $55 price target, highlighting robust volumes across health services as a positive revenue factor.
Medline is also expanding its distribution network with a new 1.2 million square foot facility in Midlothian, Texas, expected to be operational by the second quarter of 2027. This new center will be Medline’s second location in the Dallas-Fort Worth area and will increase its U.S. network to 46 distribution centers. Additionally, Medline has partnered with Symbotic to implement AI-enabled warehouse automation technology, marking the first such deployment by a healthcare company. This technology will automate picking, storage, and retrieval processes across Medline’s distribution network.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.